Literature DB >> 28234207

Effects of dopaminergic genes, prenatal adversities, and their interaction on attention-deficit/hyperactivity disorder and neural correlates of response inhibition.

Dennis van der Meer1, Catharina A Hartman1, Daan van Rooij1, Barbara Franke1, Dirk J Heslenfeld1, Jaap Oosterlaan1, Stephen V Faraone1, Jan K Buitelaar1, Pieter J Hoekstra1.   

Abstract

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is often accompanied by impaired response inhibition; both have been associated with aberrant dopamine signalling. Given that prenatal exposure to alcohol or smoking is known to affect dopamine-rich brain regions, we hypothesized that individuals carrying the ADHD risk alleles of the dopamine receptor D4 (DRD4) and dopamine transporter (DAT1) genes may be especially sensitive to their effects.
METHODS: Functional MRI data, information on prenatal adversities and genetic data were available for 239 adolescents and young adults participating in the multicentre ADHD cohort study NeuroIMAGE (average age 17.3 yr). We analyzed the effects of DRD4 and DAT1, prenatal exposure to alcohol and smoking and their interactions on ADHD severity, response inhibition and neural activity.
RESULTS: We found no significant gene × environment interaction effects. We did find that the DRD4 7-repeat allele was associated with less superior frontal and parietal brain activity and with greater activity in the frontal pole and occipital cortex. Prenatal exposure to smoking was also associated with lower superior frontal activity, but with greater activity in the parietal lobe. Further, those exposed to alcohol had more activity in the lateral orbitofrontal cortex, and the DAT1 risk variant was associated with lower cerebellar activity. LIMITATIONS: Retrospective reports of maternal substance use and the cross-sectional study design restrict causal inference.
CONCLUSION: While we found no evidence of gene × environment interactions, the risk factors under investigation influenced activity of brain regions associated with response inhibition, suggesting they may add to problems with inhibiting behaviour.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28234207      PMCID: PMC5373700          DOI: 10.1503/jpn.150350

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  62 in total

Review 1.  Neuroimaging of children following prenatal drug exposure.

Authors:  Chris Derauf; Minal Kekatpure; Nurunisa Neyzi; Barry Lester; Barry Kosofsky
Journal:  Semin Cell Dev Biol       Date:  2009-03-13       Impact factor: 7.727

Review 2.  Imaging genetics in ADHD.

Authors:  Sarah Durston
Journal:  Neuroimage       Date:  2010-03-04       Impact factor: 6.556

Review 3.  Differentiating frontostriatal and fronto-cerebellar circuits in attention-deficit/hyperactivity disorder.

Authors:  Sarah Durston; Janna van Belle; Patrick de Zeeuw
Journal:  Biol Psychiatry       Date:  2010-10-20       Impact factor: 13.382

4.  Staying on the job: the frontal lobes control individual performance variability.

Authors:  Donald T Stuss; Kelly J Murphy; Malcolm A Binns; Michael P Alexander
Journal:  Brain       Date:  2003-07-22       Impact factor: 13.501

5.  Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation.

Authors:  Sarah Durston; John A Fossella; Martijn J Mulder; B J Casey; Tim B Ziermans; M Nathalie Vessaz; Herman VAN Engeland
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

6.  Infantile autism: a total population study of reduced optimality in the pre-, peri-, and neonatal period.

Authors:  C Gillberg; I C Gillberg
Journal:  J Autism Dev Disord       Date:  1983-06

7.  Neural correlates of inhibitory control and functional genetic variation in the dopamine D4 receptor gene.

Authors:  Richard C Mulligan; Sean D Kristjansson; Angela M Reiersen; Andres S Parra; Andrey P Anokhin
Journal:  Neuropsychologia       Date:  2014-08-05       Impact factor: 3.139

8.  Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis.

Authors:  S V Faraone; T J Spencer; B K Madras; Y Zhang-James; J Biederman
Journal:  Mol Psychiatry       Date:  2013-09-24       Impact factor: 15.992

Review 9.  Does drug abuse beget drug abuse? Behavioral analysis of addiction liability in animal models of prenatal drug exposure.

Authors:  C J Malanga; Barry E Kosofsky
Journal:  Brain Res Dev Brain Res       Date:  2003-12-30

10.  Executive and motivational processes in adolescents with Attention-Deficit-Hyperactivity Disorder (ADHD).

Authors:  Maggie E Toplak; Umesh Jain; Rosemary Tannock
Journal:  Behav Brain Funct       Date:  2005-06-27       Impact factor: 3.759

View more
  3 in total

Review 1.  Gene-Environment Interactions in Psychiatry: Recent Evidence and Clinical Implications.

Authors:  Rashelle J Musci; Jura L Augustinavicius; Heather Volk
Journal:  Curr Psychiatry Rep       Date:  2019-08-13       Impact factor: 5.285

2.  Risk factors for emotional and behavioral problems in moderately-late preterms.

Authors:  Pauline J den Haan; Marlou L A de Kroon; Nienke H van Dokkum; Jorien M Kerstjens; Sijmen A Reijneveld; Arend F Bos
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

Review 3.  Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder.

Authors:  Santosh K Yadav; Ajaz A Bhat; Sheema Hashem; Sabah Nisar; Madeeha Kamal; Najeeb Syed; Mohamed-Ramzi Temanni; Rakesh K Gupta; Saddat Kamran; Muhammad Waqar Azeem; Amit K Srivastava; Puneet Bagga; Sanjeev Chawla; Ravinder Reddy; Michael P Frenneaux; Khalid Fakhro; Mohammad Haris
Journal:  Transl Psychiatry       Date:  2021-06-05       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.